Pharmac
Long-time medical director of Pharmac set to stand down
An outgoing leader at Pharmac says funding of the breast cancer drug Herceptin was the toughest decision he was involved in. Audio
Funding for new breast cancer drug disappoints
Pharmac has decided to fund a new treatment for those with aggressive breast cancer, as an alternative to Herceptin. Audio
Government side step Pharmac over Herceptin
The Government's decision to side step Pharmac and fund the breast cancer drug Herceptin is being criticised. Audio
The Herceptin Debate
The drug-buying agency Pharmac has once again said no to funding the 12 month course of the breast cancer drug, Herceptin. Audio
Cancer Drug Decision Due
Pharmac is to announce on today whether it will fund longer courses of Herceptin for women with early aggressive breast cancer Audio
Pharmac Review
The drug-buying agency has been completing it defence in a judicial review case brought by eight breast cancer patients. Audio
Legal Challenge Against Pharmac
A legal challenge is brought by eight women against Pharmac over the breast cancer drug Herceptin. Audio
Insight Sunday 12 August: Herceptin
Karen Brown explores Pharmac's decision to fund a restricted nine-week course of the breast cancer drug, Herceptin Audio